Breakthrough Study on GLP-1 Agonist Drugs Used to Treat Addiction
A research report from the Oracle Center for Real-World Data and the Parkinson School of Health Sciences shows the impact of GLP-1 agonist drugs on addiction.
Akrasia, Biased Choice, and the Unified Theory of Addiction
In concluding his book, A New Approach to Addiction and Choice, Dr. Reinout W. Wiers stumbles upon the Unified Theory of Addiction.
The Impact of GLP-1 Drugs on Sex Drive
Ozempic and other GLP-1 drugs reduce the appetite in more ways than one. We examine the impact of GLP-1 drugs on sex drive.
Are GLP-1 Drugs the Death of Desire?
GLP-1 drugs such as Ozempic, Monjourno and Wegovy appear to have the ability to suppress all desire, sometimes with negative consequences.
The Use of GLP-1 Drugs for Nicotine Use Disorder and Smoking Cessation
More and more studies show GLP-1 drugs work for smoking cessation, alcohol use disorder and opioid use disorder, but researchers aren’t sure how.
Testing GLP-1 Drugs for Substance Use Disorders
Limited human trials of GLP-1 drugs for substance use disorders indicate they might not work well for non-obese individuals.